title: Pituitary carcinoma: an ultrastructural study of eleven cases.
abstract: Pituitary carcinomas are very rare. Defined as adenohypophysial tumors that undergo craniospinal and/or systemic metastasis, most are PRL- or ACTH-producing. Their ultrastructural features, particularly relative to benign adenomas of similar functional type, have not been sufficiently explored. Eleven cases of immunohistochemically characterized pituitary carcinoma with documented cerebrospinal and/or systemic metastases were collected from various institutions and studied by transmission electron microscopy. The tumors were surgically removed from 7 women and 4 men ranging in age between 28 and 74 years (mean, 50 years). All were endocrinologically functioning. Six tumors secreted PRL; three were ACTH-producing; one each was GH/PRL- and TSH-producing. The patients with the ACTH-producing tumors had all presented with Cushing's disease and two of them had undergone adrenalectomy (Nelson syndrome). In most cases significant cellular atypia and mitotic activity were observed. In terms of morphologic features of functional differentiation, electron microscopy revealed that in 9 cases the tumor cells maintained at least some ultrastructural markers of their basic phenotype. A unique feature in 2 ACTH carcinomas was the variable admixture of smooth endoplasmic reticulum with intermediate (cytokeratin) filaments. In 2 cases, both PRL-producing carcinomas, the cell type comprising the tumor could not be identified on an ultrastructural basis alone. Ultrastructural investigation of pituitary carcinomas confirms their endocrine nature and, in most but not all cases, reveals their functional differentiation. Despite the diagnostic utility of electron microscopy in the assessment of these rare tumors, the distinction of pituitary carcinoma from pituitary adenoma cannot be firmly made on ultrastructural grounds alone.
authors.affiliation: Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: B W
authors.initials: BW
authors.lastname: Scheithauer
authors.forename: F
authors.initials: F
authors.lastname: Fereidooni
authors.forename: E
authors.initials: E
authors.lastname: Horvath
authors.forename: K
authors.initials: K
authors.lastname: Kovacs
authors.forename: P
authors.initials: P
authors.lastname: Robbins
authors.forename: D
authors.initials: D
authors.lastname: Tews
authors.forename: K
authors.initials: K
authors.lastname: Henry
authors.forename: P
authors.initials: P
authors.lastname: Pernicone
authors.forename: T A
authors.initials: TA
authors.lastname: Gaffrey
authors.forename: F B
authors.initials: FB
authors.lastname: Meyer
authors.forename: W F
authors.initials: WF
authors.lastname: Young
authors.forename: R
authors.initials: R
authors.lastname: Fahlbusch
authors.forename: M
authors.initials: M
authors.lastname: Buchfelder
authors.forename: R V
authors.initials: RV
authors.lastname: Lloyd
mesh_terms: D000236:Adenoma / Q000378:metabolism / Q000648:ultrastructure*; D000239:Adenoma, Acidophil / Q000378:metabolism / Q000648:ultrastructure; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D002277:Carcinoma / Q000378:metabolism / Q000648:ultrastructure*; D005260:Female; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000648:ultrastructure*; D011388:Prolactin / Q000378:metabolism; D013234:Stem Cells / Q000648:ultrastructure; D013972:Thyrotropin / Q000378:metabolism
chemical_list: D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013972:Thyrotropin